{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:15:54Z","timestamp":1792786554595,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Association des Scl\u00e9rodermiques de France (ASF)","id":[{"id":"https:\/\/ror.org\/013a9tb95","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.jaut.2016.03.013","type":"journal-article","created":{"date-parts":[[2016,4,3]],"date-time":"2016-04-03T08:32:13Z","timestamp":1459672333000},"page":"31-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":118,"special_numbering":"C","title":["Human adipose mesenchymal stem cells as potent anti-fibrosis therapy for systemic sclerosis"],"prefix":"10.1016","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0868-5804","authenticated-orcid":false,"given":"Alexandre T.J.","family":"Maria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Toupet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Maumus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Fonteneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Le Quellec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Jorgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Guilpain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00e8le","family":"No\u00ebl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2016.03.013_bib1","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/rheumatology\/ker269","article-title":"Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies","volume":"51","author":"Elhai","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2016.03.013_bib2","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1093\/rheumatology\/kev117","article-title":"Haematopoietic stem cell transplantation for poor-prognosis systemic sclerosis","volume":"54","author":"van Laar","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2016.03.013_bib3","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3727\/096368912X639017","article-title":"Human adipose-derived stromal cells for cell-based therapies in the treatment of systemic sclerosis","volume":"22","author":"Scuderi","year":"2013","journal-title":"Cell Transpl."},{"key":"10.1016\/j.jaut.2016.03.013_bib4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s13075-015-0819-7","article-title":"Update on mesenchymal stem cell-based therapy in lupus and scleroderma","volume":"17","author":"Cras","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2016.03.013_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/scrt55","article-title":"Mesenchymal stem cell-based therapies in regenerative medicine: applications in rheumatology","volume":"2","author":"Maumus","year":"2011","journal-title":"Stem cell Res. Ther."},{"key":"10.1016\/j.jaut.2016.03.013_bib6","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.transproceed.2008.01.080","article-title":"Therapeutic effects of bone marrow-derived mesenchymal stem cells engraftment on bleomycin-induced lung injury in rats","volume":"40","author":"Zhao","year":"2008","journal-title":"Transpl. Proc."},{"key":"10.1016\/j.jaut.2016.03.013_bib7","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2353\/ajpath.2009.080629","article-title":"Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury","volume":"175","author":"Moodley","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jaut.2016.03.013_bib8","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/iwj.12034","article-title":"Bone marrow-derived mesenchymal stem cell attenuates skin fibrosis development in mice","volume":"11","author":"Wu","year":"2014","journal-title":"Int. Wound J."},{"key":"10.1016\/j.jaut.2016.03.013_bib9","article-title":"Anti-fibrotic, anti-oxidant and immunomodulatory effects of mesenchymal stem cells in HOCl-induced systemic sclerosis","author":"Maria","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2016.03.013_bib10","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1186\/s13075-014-0442-z","article-title":"Impaired endothelium-mesenchymal stem cells cross-talk in systemic sclerosis: a link between vascular and fibrotic features","volume":"16","author":"Cipriani","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2016.03.013_bib11","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/art.22698","article-title":"Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis","volume":"56","author":"Cipriani","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.03.013_bib12","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s10456-013-9338-9","article-title":"Scleroderma mesenchymal stem cells display a different phenotype from healthy controls; implications for regenerative medicine","volume":"16","author":"Cipriani","year":"2013","journal-title":"Angiogenesis"},{"key":"10.1016\/j.jaut.2016.03.013_bib13","first-page":"211","article-title":"Alterations of ROS pathways in scleroderma begin at stem cell level","volume":"27","author":"Orciani","year":"2013","journal-title":"J.\u00a0Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.jaut.2016.03.013_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-001890","article-title":"Expression of transforming growth factor beta receptor II in mesenchymal stem cells from systemic sclerosis patients","volume":"3","author":"Vanneaux","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.jaut.2016.03.013_bib15","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1517\/14712598.2013.823153","article-title":"Adipose tissue-derived stem cells in clinical applications","volume":"13","author":"Pikula","year":"2013","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.jaut.2016.03.013_bib16","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1089\/scd.2011.0722","article-title":"Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells","volume":"21","author":"Strioga","year":"2012","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.jaut.2016.03.013_bib17","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2141.2005.05409.x","article-title":"Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells","volume":"129","author":"Puissant","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jaut.2016.03.013_bib18","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.yexcr.2007.12.022","article-title":"Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials","volume":"314","author":"Noel","year":"2008","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jaut.2016.03.013_bib19","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3389\/fimmu.2015.00560","article-title":"Comparing the immunomodulatory properties of bone marrow, adipose tissue, and birth-associated tissue mesenchymal stromal cells","volume":"6","author":"Mattar","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2016.03.013_bib20","first-page":"908","article-title":"Inhibition of liver fibrosis by IL-10 gene-modified BMSCs in a rat model","volume":"20","author":"Tu","year":"2012","journal-title":"Zhonghua gan zang bing za zhi\u00a0= Zhonghua ganzangbing zazhi\u00a0= Chin. J. Hepatol."},{"key":"10.1016\/j.jaut.2016.03.013_bib21","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/TP.0b013e31819609d9","article-title":"Comparison of transplantation of adipose tissue- and bone marrow-derived mesenchymal stem cells in the infarcted heart","volume":"87","author":"van der Bogt","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.jaut.2016.03.013_bib22","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3109\/14653249.2010.549122","article-title":"Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy","volume":"13","author":"Ikegame","year":"2011","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jaut.2016.03.013_bib23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13287-015-0142-x","article-title":"Comparison of adipose tissue- and bone marrow- derived mesenchymal stem cells for alleviating doxorubicin-induced cardiac dysfunction in diabetic rats","volume":"6","author":"Ammar","year":"2015","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.jaut.2016.03.013_bib24","doi-asserted-by":"crossref","first-page":"5855","DOI":"10.4049\/jimmunol.0803705","article-title":"Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse","volume":"182","author":"Servettaz","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.03.013_bib25","doi-asserted-by":"crossref","first-page":"e14247","DOI":"10.1371\/journal.pone.0014247","article-title":"IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis","volume":"5","author":"Bouffi","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2016.03.013_bib26","doi-asserted-by":"crossref","first-page":"R1304","DOI":"10.1186\/ar1827","article-title":"Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells","volume":"7","author":"Djouad","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2016.03.013_bib27","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1002\/art.37960","article-title":"Long-term detection of human adipose-derived mesenchymal stem cells after intraarticular injection in SCID mice","volume":"65","author":"Toupet","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.03.013_bib28","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1182\/blood-2007-02-069716","article-title":"Immunomodulatory properties of mesenchymal stromal cells","volume":"110","author":"Nauta","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2016.03.013_bib29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/scrt2","article-title":"Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications","volume":"1","author":"Ghannam","year":"2010","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.jaut.2016.03.013_bib30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/eurheartj\/ehm559","article-title":"A\u00a0placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction","volume":"29","author":"Hashemi","year":"2008","journal-title":"Eur. heart J."},{"key":"10.1016\/j.jaut.2016.03.013_bib31","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3727\/096368909788809857","article-title":"Transplantation of allogeneic and xenogeneic placenta-derived cells reduces bleomycin-induced lung fibrosis","volume":"18","author":"Cargnoni","year":"2009","journal-title":"Cell Transplant."},{"key":"10.1016\/j.jaut.2016.03.013_bib32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1089\/scd.2008.0019","article-title":"Dose-dependent effects of intravenous allogeneic mesenchymal stem cells in the infarcted porcine heart","volume":"18","author":"Wolf","year":"2009","journal-title":"Stem cells Dev."},{"key":"10.1016\/j.jaut.2016.03.013_bib33","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nbt.2816","article-title":"Mesenchymal stem cells: immune evasive, not immune privileged","volume":"32","author":"Ankrum","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jaut.2016.03.013_bib34","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1182\/blood-2005-11-011650","article-title":"Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting","volume":"108","author":"Nauta","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2016.03.013_bib35","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1159\/000343078","article-title":"Human mesenchymal stem cells reduce lung injury in immunocompromised mice but not in immunocompetent mice","volume":"85","author":"Lim","year":"2013","journal-title":"Respiration"},{"key":"10.1016\/j.jaut.2016.03.013_bib36","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/stem.1118","article-title":"Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation","volume":"30","author":"von Bahr","year":"2012","journal-title":"Stem cells"},{"key":"10.1016\/j.jaut.2016.03.013_bib37","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.biochi.2013.04.017","article-title":"Mesenchymal stem cells in regenerative medicine applied to rheumatic diseases: role of secretome and exosomes","volume":"95","author":"Maumus","year":"2013","journal-title":"Biochimie"},{"key":"10.1016\/j.jaut.2016.03.013_bib38","doi-asserted-by":"crossref","first-page":"e0114962","DOI":"10.1371\/journal.pone.0114962","article-title":"Survival and biodistribution of xenogenic adipose mesenchymal stem cells is not affected by the degree of inflammation in arthritis","volume":"10","author":"Toupet","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2016.03.013_bib39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jaut.2016.03.013_bib40","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/14653240802582075","article-title":"Human mesenchymal stromal cells from adult and neonatal sources: comparative analysis of their morphology, immunophenotype, differentiation patterns and neural protein expression","volume":"11","author":"Montesinos","year":"2009","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jaut.2016.03.013_bib41","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/cyto.a.22402","article-title":"Human adult stem cells from diverse origins: an overview from multiparametric immunophenotyping to clinical applications","volume":"85","author":"Sousa","year":"2014","journal-title":"Cytom. A"},{"key":"10.1016\/j.jaut.2016.03.013_bib42","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jcyt.2012.11.005","article-title":"Mesenchymal stromal cells: misconceptions and evolving concepts","volume":"15","author":"Phinney","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jaut.2016.03.013_bib43","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jcyt.2012.11.015","article-title":"Comparison of mesenchymal stromal cells from human bone marrow and adipose tissue for the treatment of spinal cord injury","volume":"15","author":"Zhou","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jaut.2016.03.013_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-9255-11-1","article-title":"A\u00a0comparison of adipose and bone marrow-derived mesenchymal stromal cell secreted factors in the treatment of systemic inflammation","volume":"11","author":"Elman","year":"2014","journal-title":"J.\u00a0Inflamm. (London)"},{"key":"10.1016\/j.jaut.2016.03.013_bib45","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.cellbi.2007.12.007","article-title":"Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen-stimulated B-cell immunoglobulin production in\u00a0vitro","volume":"32","author":"Bochev","year":"2008","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.jaut.2016.03.013_bib46","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.imlet.2009.07.010","article-title":"Adipose tissue-derived mesenchymal stem cells are more potent suppressors of dendritic cells differentiation compared to bone marrow-derived mesenchymal stem cells","volume":"126","author":"Ivanova-Todorova","year":"2009","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jaut.2016.03.013_bib47","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1161\/01.CIR.0000121425.42966.F1","article-title":"Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells","volume":"109","author":"Rehman","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jaut.2016.03.013_bib48","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/art.38990","article-title":"Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors","volume":"67","author":"Marangoni","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2016.03.013_bib49","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1136\/annrheumdis-2014-205681","article-title":"Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open-label phase I trial","volume":"74","author":"Granel","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.03.013_bib50","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1517\/14712590903039684","article-title":"The wound-healing and antioxidant effects of adipose-derived stem cells","volume":"9","author":"Kim","year":"2009","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.jaut.2016.03.013_bib51","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jcyt.2012.10.008","article-title":"Potency assay development for cellular therapy products: an ISCT review of the requirements and experiences in the industry","volume":"15","author":"Bravery","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jaut.2016.03.013_bib52","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1002\/stem.1982","article-title":"Establishing criteria for human mesenchymal stem cell potency","volume":"33","author":"Samsonraj","year":"2015","journal-title":"Stem Cells"},{"key":"10.1016\/j.jaut.2016.03.013_bib53","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1002\/art.39289","article-title":"Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosis","volume":"67","author":"Assassi","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2016.03.013_bib54","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.03.013_bib55","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1136\/ard.2010.144360","article-title":"Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres","volume":"70","author":"Fransen","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.03.013_bib56","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1136\/annrheumdis-2014-205226","article-title":"Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database","volume":"74","author":"Maurer","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.03.013_bib57","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1002\/art.39287","article-title":"A\u00a0longitudinal biomarker for the extent of skin disease in patients with diffuse cutaneous systemic sclerosis","volume":"67","author":"Rice","year":"2015","journal-title":"Arthritis Rheumatol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841116300269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841116300269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:13:29Z","timestamp":1760256809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841116300269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":57,"alternative-id":["S0896841116300269"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2016.03.013","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human adipose mesenchymal stem cells as potent anti-fibrosis therapy for systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2016.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}